More importantly, the overwhelming reliance on cross-sectional designs significantly restricts the ability to infer causal relationships between IL-18 and lupus nephritis (LN), or to capture dynamic changes in IL-18 levels relative to disease activity, treatment response, and pathological outcomes. This evidence concerns the gene IL18 and lobular neoplasia.